Spain OTC Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Spain OTC Drugs Statistics and the Market is Segmented by Product (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamin, Mineral, and Supplement (VMS) Products, Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Other Product Types) and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Other Distribution Channels). The Market values are Provided (in USD million) for the above segments.

Spain OTC Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Spain OTC Drugs Market Size

View Global Report
Spain Over-the-counter Drugs Market Overview
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 5.40 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Spain Over-the-counter Drug Companies

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Spain Over-the-counter (OTC) Drugs Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Spain OTC Drugs Market Analysis

The Spain Over-the-counter Drugs Market is expected to register a CAGR of 5.4% during the forecast period.

During the COVID-19 situation, where the population is generally avoiding hospital and clinic visits unless necessary, the trend of self-medication has been observed to increase exponentially. Over-the-counter (OTC) medicines are witnessing an unprecedented demand amid the COVID-19 crisis, owing to the restricted visits to hospitals and health professionals. For instance, in March 2020, Sandoz, one of the largest medicine providers, in Europe reported that it was increasing supplies of key antibiotics needed to respond to the COVID-19 crisis owing to the increased demand in the European countries.

The major factors propelling the growth of the Spain OTC drugs market include product innovation, growing distribution channels, an inclination of the pharmaceutical companies from Rx to OTC drugs, and increasing self-medication among the general population. The increasing healthcare costs demand better accessibility and affordability of healthcare services. Self-medication with non-prescription drugs has increased in the past years owing to its advantages, such as it helps improve the accessibility and cost benefits of healthcare services. Thus, there is an increase in the trend toward self-medication in European countries, including Spain.

For instance, a report published in June 2020, titled "Spain Pharma Market & Regulatory Report" stated that according to the Spain's pharmaceutical market with patented drugs comprising 81% of the total in 2019 at a value of USD 24.45 billion. The generic drugs accounted for a low 14.3% of the market and over-the-counter (OTC) medicines accounted for just 4.7% of the market. The same source that, from November 1 2019, Spain's Ministry of Health implemented a price reduction across 16,454 medicines. These price cuts will impact prescription (pharmacy and hospital setting) and OTC medicines, which are expected to reduce public expenditure on medicines by USD 129 million a year. Such intitatives by the government would support the growth of the market in upcoming period.

Thus, owing to the abovementioned factors, market is expected to show growth over the forecast period. However, incorrect self diagnosis and probability of self abuse may hinder the growth of the market.

Spain OTC Drugs Industry Overview

The Spain over-the-counter (OTC) drugs market is highly competitive. There are some major players that are holding the major share, along with some smaller companies holding a substantial share. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices. Key players in the market are Bayer, Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, and Reckitt Benckiser Group PLC, among others.

Spain OTC Drugs Market Leaders

  1. Sanofi SA

  2. GlaxoSmithKline PLC

  3. Bayer

  4. Pfizer Inc

  5. Reckitt Benckiser Group PLC

  6. *Disclaimer: Major Players sorted in no particular order
Sanofi SA, GlaxoSmithKline PLC, Bayer, Pfizer Inc, Reckitt Benckiser Group PLC.
Need More Details on Market Players and Competiters?
Download PDF

Spain OTC Drugs Market News

In October 2021, Glenmark launched the Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus in Spain for the treatment of chronic obstructive pulmonary disease (COPD).

In January 2021, Pfizer Inc. invested a total of USD 120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI).

Spain OTC Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Inclination of Pharmaceutical Companies to Switch From Rx to OTC Drugs
    • 4.2.2 Increasing Self Medication Among the General Population
    • 4.2.3 High Penetration in Emerging Markets
  • 4.3 Market Restraints
    • 4.3.1 Incorrect Self Diagnosis
    • 4.3.2 Probability of Substance Abuse
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Cough, Cold, and Flu Products
    • 5.1.2 Analgesics
    • 5.1.3 Dermatology Products
    • 5.1.4 Gastrointestinal Products
    • 5.1.5 Vitamin, Mineral, and Supplement (VMS) Products
    • 5.1.6 Weight-loss/Dietary Products
    • 5.1.7 Ophthalmic Products
    • 5.1.8 Sleeping Aids
    • 5.1.9 Other Product Types
  • 5.2 By Distribution Channel
    • 5.2.1 Retail Pharmacies
    • 5.2.2 Online Pharmacies
    • 5.2.3 Other Distribution Channels

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Astrazeneca PLC
    • 6.1.2 Bayer
    • 6.1.3 Bristol-Myers Squibb
    • 6.1.4 Cardinal Health
    • 6.1.5 GlaxoSmithKline PLC
    • 6.1.6 Johnson and Johnson
    • 6.1.7 Leo Pharma AS
    • 6.1.8 Procter & Gamble ( Merck & Co.)
    • 6.1.9 Novartis AG
    • 6.1.10 Pfizer Inc.
    • 6.1.11 Reckitt Benckiser Group PLC
    • 6.1.12 Sanofi SA
    • 6.1.13 Takeda Pharamaceutical Company Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Spain OTC Drugs Industry Segmentation

Over-the-counter (OTC) medications do not need a doctor's prescription. This convenience for consumers enables the direct purchase of medicines. The Spain over-the-counter (OTC) drugs market is segmented by product (cough, cold, and flu products, analgesics, dermatology products, gastrointestinal products, vitamin, mineral, and supplement (VMS) products, weight-loss/dietary products, ophthalmic products, sleeping aids, and other product types) and distribution channel (retail pharmacies, online pharmacies, and other distribution channels). The report offers the value (in USD million) for the above segments.

By Product Cough, Cold, and Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamin, Mineral, and Supplement (VMS) Products
Weight-loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Other Product Types
By Distribution Channel Retail Pharmacies
Online Pharmacies
Other Distribution Channels
Need A Different Region or Segment?
Customize Now

Spain OTC Drugs Market Research FAQs

What is the current Spain Over-the-counter (OTC) Drugs Market size?

The Spain Over-the-counter (OTC) Drugs Market is projected to register a CAGR of 5.4% during the forecast period (2025-2030)

Who are the key players in Spain Over-the-counter (OTC) Drugs Market?

Sanofi SA, GlaxoSmithKline PLC, Bayer, Pfizer Inc and Reckitt Benckiser Group PLC are the major companies operating in the Spain Over-the-counter (OTC) Drugs Market.

Which is the fastest growing region in Spain Over-the-counter (OTC) Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Spain Over-the-counter (OTC) Drugs Market?

In 2025, the North America accounts for the largest market share in Spain Over-the-counter (OTC) Drugs Market.

What years does this Spain Over-the-counter (OTC) Drugs Market cover?

The report covers the Spain Over-the-counter (OTC) Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Spain Over-the-counter (OTC) Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Spain OTC Drugs Industry Report

Statistics for the 2025 Spain Over-the-counter (OTC) Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Spain Over-the-counter (OTC) Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.